Instandhaltungskoordinator (m/w/d) im Fertigungsbereich at Clairo

Hanover, Lower-Saxony, Germany

Clairo Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Battery Technology, Automotive, ManufacturingIndustries

Requirements

  • Abgeschlossene 3,5-jährige, technische Berufsausbildung (Weiterbildung zum Industriemeister/Techniker wünschenswert)
  • Einschlägige Berufserfahrung und Projekterfahrung
  • Einsatzbereitschaft, Flexibilität und Motivation
  • Gute Englischkenntnisse in Wort und Schrift

Responsibilities

  • Vertretung der Instandhaltungsleitung (m/w/d) eines Fertigungsbereichs
  • Einführung und Umsetzung technischer Projekte zur Optimierung von Maschinen und Anlagen in Abstimmung mit relevanten Schnittstellen
  • Identifikation technischer Ausfallschwerpunkte auf Basis von Störungsdaten aus den eingesetzten Systemen
  • Vorbereitung der Auswahl geeigneter Fremdfirmen sowie deren Betreuung und Koordination während Projekt- oder Wartungsphasen
  • Verantwortung für die Durchführung von Wartungsmaßnahmen in enger Zusammenarbeit mit der Instandhaltungsleitung
  • Analyse von Störungen und Entwicklung geeigneter Maßnahmen zur nachhaltigen Störungsbehebung
  • Installation und Inbetriebnahme neuer Anlagen sowie Einbringung innovativer Ideen zur Prozessverbesserung

Skills

Maintenance Coordination
Project Management
Fault Analysis
Machine Optimization
Vendor Management
Preventive Maintenance
Installation
Commissioning
Process Improvement
Data Analysis
English

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI